Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.98 USD | +2.15% | +8.71% | +29.95% |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 548M |
---|---|---|---|---|---|
Net income 2024 * | -79M | Net income 2025 * | -101M | EV / Sales 2024 * | - |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-6.45
x | P/E ratio 2025 * |
-5.07
x | Employees | 59 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.7% |
Latest transcript on Astria Therapeutics, Inc.
1 day | +2.15% | ||
1 week | +8.71% | ||
Current month | +8.71% | ||
1 month | -11.45% | ||
3 months | -32.52% | ||
6 months | +104.30% | ||
Current year | +29.95% |
Managers | Title | Age | Since |
---|---|---|---|
Jill Milne
FOU | Founder | 56 | 08-06-25 |
Noah Clauser
DFI | Director of Finance/CFO | 51 | 11-03-31 |
Chief Tech/Sci/R&D Officer | - | 22-07-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ken Bate
CHM | Chairman | 73 | 13-12-31 |
Gregg Lapointe
BRD | Director/Board Member | 65 | 19-01-03 |
Director/Board Member | 75 | 16-04-04 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.03% | 2 M€ | -.--% | ||
0.00% | 0 M€ | +3.53% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-07 | 9.98 | +2.15% | 420,278 |
24-05-06 | 9.77 | +2.30% | 496,047 |
24-05-03 | 9.55 | +2.14% | 537,584 |
24-05-02 | 9.35 | -1.58% | 807,906 |
24-05-01 | 9.5 | +3.49% | 2,724,503 |
Delayed Quote Nasdaq, May 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.95% | 548M | |
+10.44% | 107B | |
+0.82% | 106B | |
+6.72% | 23.47B | |
-13.89% | 21.9B | |
-6.64% | 18.77B | |
-37.26% | 17.85B | |
-10.98% | 16.78B | |
+8.67% | 14.41B | |
+41.08% | 12.86B |
- Stock Market
- Equities
- ATXS Stock